Neuroblast Differentiation-Associated Protein Derived Polypeptides: AHNAK(5758-5775) Induces Inflammation by Activating Mast Cells via ST2

References

• Ahmad SF, Ansari MA, Nadeem A, Alzahrani MZ, Bakheet SA, Attia SM. 2018. Resveratrol improves neuroimmune dysregulation through the inhibition of neuronal toll-like receptors and cox-2 signaling in BTBR T(+) Itpr3(tf)/J Mice. Neuromolecular Med. 20(1):133–46.
   PubMed Web of Science ®Google Scholar
• Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Al-Ayadhi LY, Attia SM. 2017. Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T + Itpr3 tf /J mice. Prog Neuropsychopharmacol Biol Psychiatry. 79(Pt B):184–91.
   PubMedGoogle Scholar
• Ahmad SF, Ansari MA, Nadeem A, Zoheir KMA, Bakheet SA, Al-Shabanah OA, Al Rikabi AC, Attia SM. 2016. The tyrosine kinase inhibitor tyrphostin AG126 reduces activation of inflammatory cells and increases Foxp3(+) regulatory T cells during pathogenesis of rheumatoid arthritis. Mol Immunol. 78:65–78.
   PubMed Web of Science ®Google Scholar
• Al-Harbi NO, Nadeem A, Ahmad SF, Bakheet SA, El-Sherbeeny AM, Ibrahim KE, Alzahrani KS, Al-Harbi MM, Mahmood HM, Alqahtani F, et al. 2020. Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells. Eur J Pharmacol. 877:173088.
   PubMed Web of Science ®Google Scholar
• Aung G, Niyonsaba F, Ushio H, Kajiwara N, Saito H, Ikeda S, Ogawa H, Okumura K. 2011. Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines. Immunology. 132(4):527–39.
   PubMed Web of Science ®Google Scholar
• Chen B, Wang J, Dai D, Zhou Q, Guo X, Tian Z, Huang X, Yang L, Tang H, Xie X. 2017. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer. J Exp Clin Cancer Res. 36(1):65.
   PubMedGoogle Scholar
• Chiricozzi A, Romanelli P, Volpe E, Borsellino G, Romanelli M. 2018. Scanning the immunopathogenesis of psoriasis. Int J Mol Sci. 19(1):179.
   PubMed Web of Science ®Google Scholar
• Choi EW, Lee HW, Lee JS, Kim IY, Shin JH, Seong JK. 2019. Ahnak-knockout mice show susceptibility to Bartonella henselae infection because of CD4+ T cell inactivation and decreased cytokine secretion. BMB Rep. 52(4):289–94.
   PubMed Web of Science ®Google Scholar
• Conti P, Pregliasco FE, Bellomo RG, Gallenga CE, Caraffa A, Kritas SK, Lauritano D, Ronconi G. 2021. Mast cell cytokines IL-1, IL-33, and IL-36 mediate skin inflammation in psoriasis: a novel therapeutic approach with the anti-inflammatory cytokines IL-37, IL-38, and IL-1Ra. Int J Mol Sci. 22(15):8076.
   PubMed Web of Science ®Google Scholar
• Davis TA, Loos B, Engelbrecht AM. 2014. AHNAK: the giant jack of all trades. Cell Signal. 26(12):2683–93.
   PubMed Web of Science ®Google Scholar
• Gong X, Wang W. 2021. Profiles of innate immune cell infiltration and related core genes in psoriasis. Biomed Res Int. 2021:6656622.
   PubMed Web of Science ®Google Scholar
• Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. 2021. Psoriasis. Lancet. 397(10281):1301–15.
   PubMed Web of Science ®Google Scholar
• Harvima IT, Nilsson G, Suttle M-M, Naukkarinen A. 2008. Is there a role for mast cells in psoriasis? Arch Dermatol Res. 300(9):461–78.
   PubMed Web of Science ®Google Scholar
• Homsak E, Gruson D. 2020. Soluble ST2: a complex and diverse role in several diseases. Clin Chim Acta. 507:75–87.
   PubMed Web of Science ®Google Scholar
• Hueber AJ, Alves-Filho JC, Asquith DL, Michels C, Millar NL, Reilly JH, Graham GJ, Liew FY, Miller AM, McInnes IB. 2011. IL-33 induces skin inflammation with mast cell and neutrophil activation. Eur J Immunol. 41(8):2229–37.
   PubMed Web of Science ®Google Scholar
• Karhu T, Akiyama K, Vuolteenaho O, Bergmann U, Naito T, Tatemoto K, Herzig K-H. 2017. Mast cell degranulation via MRGPRX2 by isolated human albumin fragments. Biochim Biophys Acta Gen Subj. 1861(11 Pt A):2530–34.
   PubMed Web of Science ®Google Scholar
• Lanna C, Mancini M, Gaziano R, Cannizzaro MV, Galluzzo M, Talamonti M, Rovella V, Annicchiarico-Petruzzelli M, Melino G, Wang Y, et al. 2019. Skin immunity and its dysregulation in psoriasis. Cell Cycle. 18(20):2581–89.
   PubMed Web of Science ®Google Scholar
• Lee IH, Sohn M, Lim HJ, Yoon S, Oh H, Shin S, Shin JH, Oh S-H, Kim J, Lee DK, et al. 2014. Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway. Oncogene. 33(38):4675–84.
   PubMed Web of Science ®Google Scholar
• Li L, Liu Y, Feng T, Zhou W, Wang Y, Li H. 2022. The AHNAK induces increased IL-6 production in CD4+ T cells and serves as a potential diagnostic biomarker for recurrent pregnancy loss. Clin Exp Immunol. 209(3):291–304.
   PubMed Web of Science ®Google Scholar
• Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, Villanueva EC, Shah P, Kaplan MJ, Bruce AT. 2011. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol. 187(1):490–500.
   PubMed Web of Science ®Google Scholar
• Lu L, Kulka M, Unsworth LD. 2017. Peptide-mediated mast cell activation: ligand similarities for receptor recognition and protease-induced regulation. J Leukoc Biol. 102(2):237–51.
   PubMed Web of Science ®Google Scholar
• Martin-Avila A, Medina-Tamayo J, Ibarra-Sánchez A, Vázquez-Victorio G, Castillo-Arellano JI, Hernández-Mondragón AC, Rivera J, Madera-Salcedo IK, Blank U, Macías-Silva M, et al. 2016. Protein tyrosine kinase Fyn regulates TLR4-elicited responses on mast cells controlling the function of a PP2A-PKCα/β signaling node leading to TNF secretion. J Immunol. 196(12):5075–88.
   PubMed Web of Science ®Google Scholar
• Mashiko S, Bouguermouh S, Rubio M, Baba N, Bissonnette R, Sarfati M. 2015. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. J Allergy Clin Immunol. 136(2):351–9 e1.
   PubMed Web of Science ®Google Scholar
• Mitsui A, Tada Y, Takahashi T, Shibata S, Kamata M, Miyagaki T, Fujita H, Sugaya M, Kadono T, Sato S, et al. 2016. Serum IL-33 levels are increased in patients with psoriasis. Clin Exp Dermatol. 41(2):183–89.
   PubMed Web of Science ®Google Scholar
• Nadeem A, Ahmad SF, Al-Harbi NO, El-Sherbeeny AM, Al-Harbi MM, Almukhlafi TS. 2017. GPR43 activation enhances psoriasis-like inflammation through epidermal upregulation of IL-6 and dual oxidase 2 signaling in a murine model. Cell Signal. 33:59–68.
   PubMed Web of Science ®Google Scholar
• Nadeem A, Ahmad SF, El-Sherbeeny AM, Al-Harbi NO, Bakheet SA, Attia SM. 2018. Systemic inflammation in asocial BTBR T(+) tf/J mice predisposes them to increased psoriatic inflammation. Prog Neuropsychopharmacol Biol Psychiatry. 83:8–17.
   PubMed Web of Science ®Google Scholar
• Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. 2020. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 369:m1590.
   PubMed Web of Science ®Google Scholar
• Rendon A, Schakel K. 2019. Psoriasis pathogenesis and treatment. Int J Mol Sci. 20(6):1475.
   PubMed Web of Science ®Google Scholar
• Saluja R, Khan M, Church MK, Maurer M. 2015. The role of IL-33 and mast cells in allergy and inflammation. Clin Transl Allergy. 5(1):33.
   PubMedGoogle Scholar
• Sheppard HM, Feisst V, Chen J, Print C, Dunbar PR. 2016. AHNAK is downregulated in melanoma, predicts poor outcome, and may be required for the expression of functional cadherin-1. Melanoma Res. 26(2):108–16.
   PubMed Web of Science ®Google Scholar
• Skoldberg F, Rönnblom L, Thornemo M, Lindahl A, Bird PI, Rorsman F, Kämpe O, Landgren E. 2002. Identification of AHNAK as a novel autoantigen in systemic lupus erythematosus. Biochem Biophys Res Commun. 291(4):951–58.
   PubMed Web of Science ®Google Scholar
• Sudo H, TSUJI AB, SUGYO A, ABE M, HINO O, SAGA T. 2014. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma. Int J Oncol. 44(2):530–38.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Yamasaki K. 2020. Psoriasis and antimicrobial peptides. Int J Mol Sci. 21(18):6791.
   PubMed Web of Science ®Google Scholar
• Ten Bergen LL, Petrovic A, Aarebrot AK, Appel S. 2020. Current knowledge on autoantigens and autoantibodies in psoriasis. Scand J Immunol. 92(4):e12945.
   PubMed Web of Science ®Google Scholar
• Welihinda A, Ravikumar P, Kaur M, Mechanic J, Yadav S, Kang GJ, Amento E. 2022. Positive allosteric modulation of A2AR alters immune cell responses and ameliorates psoriasis-like dermatitis in mice. J Invest Dermatol. 142(3):624–32 e6.
   PubMed Web of Science ®Google Scholar
• Yu Y, Blokhuis BR, Garssen J, Redegeld FA. 2016. Non-IgE mediated mast cell activation. Eur J Pharmacol. 778:33–43.
   PubMed Web of Science ®Google Scholar
• Zardab M, Stasinos K, Grose RP, Kocher HM. 2022. The obscure potential of AHNAK2. Cancers (Basel). 14(3):528.
   PubMed Web of Science ®Google Scholar
• Zelechowska P, Agier J, Różalska S, Wiktorska M, Brzezińska-Błaszczyk E. 2018. Leptin stimulates tissue rat mast cell pro-inflammatory activity and migratory response. Inflamm Res. 67(9):789–99.
   PubMed Web of Science ®Google Scholar